These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24612357)

  • 1. Erythroderma as drug eruption induced by intravesical mitomycin C therapy.
    Igawa K; Konishi M; Moriyama Y; Fukuyama K; Yokozeki H
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):613-4. PubMed ID: 24612357
    [No Abstract]   [Full Text] [Related]  

  • 2. Exfoliative dermatitis following intravesical therapy with mitomycin C.
    Bencini PL; Sala F; Crosti C; Nobili M; Bertani E
    Int J Dermatol; 1985 Sep; 24(7):472. PubMed ID: 2932403
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.
    Okumura A; Oishi N; Kaji K; Imamura T; Fuse H
    J Dermatol; 2009 Jul; 36(7):419-22. PubMed ID: 19583691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III and type IV hypersensitivity reactions due to mitomycin C.
    Kunkeler L; Nieboer C; Bruynzeel DP
    Contact Dermatitis; 2000 Feb; 42(2):74-6. PubMed ID: 10703627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal erythroderma associated with pentostatin.
    Ghura HS; Carmichael AJ; Bairstow D; Finney R
    BMJ; 1999 Aug; 319(7209):549. PubMed ID: 10463896
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudoscleroderma possibly induced by intravesical instillation of mitomycin C.
    Calistru AM; Baudrier T; Mota A; Alexandrescu D; Cunha AL; Silva J; Azevedo F
    J Am Acad Dermatol; 2010 Dec; 63(6):e116-8. PubMed ID: 21093658
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical mitomycin C-induced generalized pustular folliculitis.
    Andreu-Barasoain M; Gómez de la Fuente E; Pinedo F; Nuño A; López-Estebaranz JL
    J Am Acad Dermatol; 2012 Oct; 67(4):e142-3. PubMed ID: 22980268
    [No Abstract]   [Full Text] [Related]  

  • 8. Necrosis of the glans penis: a rare complication of intravesical therapy with mitomycin c.
    Neulander EZ; Lismer L; Kaneti J
    J Urol; 2000 Oct; 164(4):1306. PubMed ID: 10992393
    [No Abstract]   [Full Text] [Related]  

  • 9. A very rare side effect of mitomycin-C: psoriasiform drug eruption.
    Cicek D; Cobanoglu B; Inci R; Dertlioglu SB; Kokcam I; Elkiran T
    Int J Dermatol; 2013 Dec; 52(12):1572-4. PubMed ID: 24261729
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravesical mitomycin-C-induced interstitial pneumonia.
    Wada H; Nakano Y; Yamada H; Saiga T; Yamanaka A; Sakai N
    Respiration; 2010; 80(3):256-9. PubMed ID: 20130385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.
    Clark T; Chang SS; Cookson MS
    J Urol; 2002 Apr; 167(4):1795. PubMed ID: 11912421
    [No Abstract]   [Full Text] [Related]  

  • 12. Urethral slough: a rare and previously unreported complication of intravesical mitomycin.
    Brady JD; Assimos DG; Jordan GH
    J Urol; 2000 Oct; 164(4):1305. PubMed ID: 10992392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liposomal doxorubicin and palmoplantar erythrodysesthesia].
    Tomb R; Stephan F; Halaby G
    Ann Dermatol Venereol; 2003 Nov; 130(11):1057-8. PubMed ID: 14724543
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythroderma secondary to gliclazide: a case report.
    Ozuguz P; Kacar SD; Ozuguz U; Karaca S; Tokyol C
    Cutan Ocul Toxicol; 2014 Dec; 33(4):342-4. PubMed ID: 24641117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic cystitis following immediate post-resection intravesical instillation of mitomycin-C.
    Caso J; Qin D; Sexton WJ
    Can J Urol; 2010 Jun; 17(3):5223-5. PubMed ID: 20566021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder].
    Cuervo Pinna MA; Cuervo Pinna C; Macías Castillo S; Bureo Dacal JC; Espada Alonso MJ; Pimentel Leo J
    An Med Interna; 2001 Dec; 18(12):641-3. PubMed ID: 11852501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical mitomycin C for superficial transitional cell carcinoma.
    Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
    Kalsi J; Harland SJ; Feneley MR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bladder necrosis after an immediate post-operative mitomycin C instillation].
    Branchereau J; Luyckx F; Hitier M; Karam G; Bouchot O; Rigaud J
    Prog Urol; 2011 Feb; 21(2):151-3. PubMed ID: 21296285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous complications of intravesical treatments for bladder cancer: granulomatous inflammation of the penis following BCG therapy and penile gangrene following mitomycin therapy.
    Kureshi F; Kalaaji AN; Halvorson L; Pittelkow MR; Davis MD
    J Am Acad Dermatol; 2006 Aug; 55(2):328-31. PubMed ID: 16844523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.